Liver Disease Risk Factors in Patients Treated for Alcohol and Drug Dependence

Conclusion As this was only a pilot study, further data collection involving a larger, representative sample of clients should be undertaken to explore these results further. References Bennett, H. et al., 2015. Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections. PLoS ONE, 10(5), p.e0125846. Edeghere, O. et al., 2015. Retrospective cohort study of liver transplantation in the United Kingdom between 1994 and 2010: the impact of hepatitis C infection. Public Health, 129(5), pp.509–516. Gossop, M. et al., 2003. Alcohol use outcomes and heavy drinking at 4-5 years among a treatment sample of drug misusers. Journal of Substance Abuse Treatment, 25(3), pp.135–143. Nelson, P.K. et al., 2011. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet, 378(9791), pp.571–583. Public Health England, 2017. Adult Drug Statistics from the National Drug Treatment Monitoring System (NDTMS): 1 April 2016 to 31 March 2017. Smith-Palmer, J., Cerri, K. & Valentine, W., 2015. Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits. BMC Infectious Diseases, 15(1), pp.1–19. Staiger, P.K. et al., 2013. Overlooked and underestimated? Problematic alcohol use in clients recovering from drug dependence. Addiction, 108(7),...
Source: Alcohol Research UK - Category: Addiction Authors: Tags: Alcohol Insights Source Type: news